Please login to the form below

Not currently logged in
Email:
Password:

New Accounts, April, 2009 - PR & Med Ed

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

New pharmaceutical account wins notified to us by the winning agency for the period February 2009 and March 2009 inclusive:

 

CLIENT

PRODUCT

THERAPEUTIC AREA

WINNING AGENCY

AstraZeneca RECENTIN Recurrent glioblastoma multiforme and colorectal cancer IMC Medical Communication
AstraZeneca  ZD4054 Prostate cancer IMC Medical Communication
Celgene Vidaza Haematology Succinct Healthcare Communications
EMD Serono
n/a
Infertility Medaxial
Genzyme Mozobil Oncology Medaxial
Genzyme Thyrogen endocrinology / oncology
Medaxial
Lifeblood: The Thrombosis Charity
National Thrombosis Awareness Week
Corporate Athena
Napp Pharmaceuticals
Targinact Pain Flutter & Wow
Novartis
Exelon patch
Neuroscience
Just::
Novartis global
Stalevo
Neuroscience
Just::
Novartis Oncology International
Zometa
Oncology
PraeMedica
Sanofi-aventis/Bristol-Myers Squibb
n/a
Cardiovascular
Medaxial
SPD Development Company
Clearblue digital pregnancy test
Women's health
IMC Medical Communications
Wyeth ReFacto Haemophilia ROAD 

  

Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may not be involved with some of the products listed in other ways, or in domestic, overseas or international markets.

To submit an entry for New Accounts, email new_accounts@pmlive.com

12th May 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Create Health

A healthcare marketing agency that shares your passion for making things better. Our clients with solve real health problems every...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Biomarker
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...

Infographics